Edition:
United States

Genfit SA (GNFT.PA)

GNFT.PA on Paris Stock Exchange

24.02EUR
22 Jun 2018
Change (% chg)

€-0.08 (-0.33%)
Prev Close
€24.10
Open
€24.06
Day's High
€24.12
Day's Low
€23.86
Volume
81,971
Avg. Vol
166,761
52-wk High
€31.60
52-wk Low
€20.11

Select another date:

Fri, Apr 27 2018

BRIEF-Genfit's Q1 revenues edge up compared to a year ago

* Revenues for the first three months of 2018 amounted to €37 thousand compared to €26 thousand for the same period in 2017

BRIEF-Genfit Announces Positive Outcome From The Safety Review By The DSMB

* REG-GENFIT : POSITIVE OUTCOME FROM THE 24-MONTH PRE-PLANNED SAFETY REVIEW BY THE DSMB, IN RESOLVE-IT PHASE 3 CLINICAL TRIAL WITH ELAFIBRANOR

BRIEF-Genfit announces milestone for RESOLVE-IT Phase 3 Trial

* Major Milestone for the RESOLVE-IT Phase 3 Trial on the Recruitment of the Interim Analysis Cohort

BRIEF-Genfit FY Net Loss Widens To 58.6 Million Euros

* 2017: A YEAR OF VERY SIGNIFICANT REINFORCEMENT OF THE CASH POSITION (€274M AT 12.31.2017), WITH ALL PROGRAMS IN THE COMPANY'S PIPELINE MOVING FORWARD

BRIEF-Genfit: Official Launch Of NASH Pediatric Program In US

* REG-GENFIT: OFFICIAL LAUNCH OF THE NASH PEDIATRIC PROGRAM, FOLLOWING PIP AND PSP AGREEMENT BY EMA AND FDA

Select another date: